HomeBICO • STO
BICO Group AB
kr 32.88
Jan 30, 6:00:00 PM GMT+1 · SEK · STO · Disclaimer
StockSE listed security
Previous close
kr 32.92
Day range
kr 32.52 - kr 34.02
Year range
kr 28.18 - kr 61.12
Market cap
2.27B SEK
Avg Volume
107.62K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK)Sep 2024Y/Y change
Revenue
495.50M-15.67%
Operating expense
312.80M-7.57%
Net income
-246.20M-252.22%
Net profit margin
-49.69-317.56%
Earnings per share
EBITDA
36.90M-60.79%
Effective tax rate
-5.77%
Total assets
Total liabilities
(SEK)Sep 2024Y/Y change
Cash and short-term investments
649.80M15.62%
Total assets
5.47B-38.24%
Total liabilities
2.70B-7.93%
Total equity
2.77B
Shares outstanding
70.57M
Price to book
0.84
Return on assets
-2.22%
Return on capital
-2.58%
Net change in cash
(SEK)Sep 2024Y/Y change
Net income
-246.20M-252.22%
Cash from operations
45.00M1,150.00%
Cash from investing
-27.30M73.08%
Cash from financing
-18.30M36.90%
Net change in cash
-5.30M95.88%
Free cash flow
-269.76M-250.45%
About
Bico Group is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics. Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet. The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
Founded
Jan 27, 2016
Website
Employees
824
Search
Clear search
Close search
Google apps
Main menu